Portefeuille d'ETF LABU (NYSE) - Page 6 | MetaTrader

Afficher le graphique complet Full chart

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

TSHA Taysha Gene Therapies Inc. 1.0 M 228.7 K 0.2%

KURA Kura Oncology Inc. 1.0 M 124.3 K 0.2%

RIGL Rigel Pharmaceuticals Inc. 996.8 K 28.6 K 0.2%

NRIX Nurix Therapeutics Inc. 992.0 K 60.0 K 0.2%

RLAY Relay Therapeutics Inc 984.6 K 128.5 K 0.2%

GLUE Monte Rosa Therapeutics Inc 918.0 K 44.7 K 0.2%

ERAS Erasca Inc 913.5 K 86.9 K 0.2%

KOD Kodiak Sciences Inc 899.1 K 39.5 K 0.2%

ORKA Oruka Therapeutics Inc 873.9 K 25.5 K 0.2%

SANA Sana Biotechnology Inc 805.7 K 181.9 K 0.1%

PVLA Palvella Therapeutics Inc. 800.6 K 10.4 K 0.1%

UPB Upstream Bio Inc 797.7 K 25.7 K 0.1%

XNCR Xencor Inc 784.0 K 64.8 K 0.1%

OLMA Olema Pharmaceuticals Inc. 767.9 K 29.9 K 0.1%

SPRY ARS Pharmaceuticals Inc 765.9 K 76.7 K 0.1%

GERN Geron Corp. 747.0 K 545.2 K 0.1%

ALT Altimmune Inc. 727.3 K 129.9 K 0.1%

SION Sionna Therapeutics Inc. 692.3 K 16.4 K 0.1%

KALV KalVista Pharmaceuticals Inc. 679.3 K 43.5 K 0.1%

EBS Emergent Biosolutions Inc 669.7 K 59.1 K 0.1%

1
2
3
4
5
6
7
8

Nouvelles

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies

Finally Coming Into View? 'Old-Economy' Stocks Show Their Colors